article thumbnail

Product Highlight: DrugBank on Snowflake Marketplace

DrugBank

That’s why DrugBank is making it easier than ever to access our data packages through Snowflake Marketplace, allowing you to explore and trial our offerings seamlessly to support your work and enhance decision-making. This integration is designed with you in mind, delivering a smooth, reliable experience.

article thumbnail

Over The Air Updates for React Native Apps

Perficient: Drug Development

package which added the following dependencies. OTA Deployment: Execute the command via terminal: EAS_CHANNEL=staging RUNTIME_VERSION="7.13" eas update --message "build:[QA] - 7.13.841 - 25.5.9.4 - OTA Test2 commit" Once the package is published, I can see my update available in expo.dev as shown in the image below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI and LLMs are transforming drug discovery: part 1

Drug Target Review

These organisations not only embraced AI right away for processing information, but they were using many technologies we’re just discovering now, 5-10 years ago. The opportunity lies in packaging AI into controlled environments where we understand inputs, possible outputs, and have monitoring systems.

Drugs 69
article thumbnail

Gene editing extends lifespan in mouse model of prion disease

Broad Institute

We are hopeful the results might inform the future development of a one-time treatment for this important class of diseases. We realized it was this golden opportunity to use human genetics to inform base editing, Minikel said. But the researchers needed to deliver the base editors to the brain.

Disease 144
article thumbnail

Accepting new applications for ACE program 2025

Predictive Oncology

This information can improve the probability of technical success and strengthen the data package for the commercialization of submitted compounds. Applications for inclusion in the ACE program for Q4 2025 will be accepted starting June 15th, 2025.

article thumbnail

Overcoming Orphan Drug Development Challenges with Real-World Data and Evidence

PPD

Addressing evidence gaps early enables health technology developers to optimize their development strategies and plan their health economic modelling sooner, to provide robust and comprehensive evidence packages that support their product’s value proposition.

article thumbnail

CMC and the Critical Path to NDA: The Journey from Molecule to Market

The Premier Consulting Blog

The CMC component of an NDA provides detailed information on the investigational drugs composition, manufacturing processes, quality controls, and stability. It ensures that the product is produced consistently and controlled in accordance with the quality standards suitable for its intended use.